Cost-effectiveness of different treat-to-target strategies in rheumatoid arthritis: results from the DREAM registry

por van de Laar, Celine J., Oude Voshaar, Martijn A. H., Vonkeman, Harald E.
Publicado 2019

Vaccine-induced immune thrombocytopenia and thrombosis after mRNA-1273 booster vaccination

por Langerak, T., Bakker, G.J., Porcelijn, L., Lauw, M.N., van de Laar, R.J., Eefting, M.
Publicado 2022

Spontaneous Clearance of Hepatitis C Virus Infection Among Human Immunodeficiency Virus–Infected Men Who Have Sex With Men

por Newsum, Astrid M., Schinkel, Janke, van de Laar, Thijs J. W., van der Meer, Jan T. M., Prins, Maria
Publicado 2017

Comparison of the Performance of the PanBio COVID-19 Antigen Test in SARS-CoV-2 B.1.1.7 (Alpha) Variants versus non-B.1.1.7 Variants

por van Ogtrop, M. L., van de Laar, T. J. W., Eggink, D., Vanhommerig, J. W., van der Reijden, W. A.
Publicado 2021

Lower Incidence of Parvovirus-B19 Infections in Dutch Blood Donors during SARS-CoV-2 Pandemic

por Molenaar-de Backer, M. W., Hogema, B. M., Koppelman, M. H., van de Laar, T. J., Slot, E., Zaaijer, H. L.
Publicado 2021

Never injected, but hepatitis C virus-infected: a study among self-declared never-injecting drug users from the Amsterdam Cohort Studies

por van den Berg, C H S B, van de Laar, T J W, Kok, A, Zuure, F R, Coutinho, R A, Prins, M
Publicado 2009

Decrease in viral hepatitis diagnoses during the COVID-19 pandemic in the Netherlands

por Sonneveld, Milan J., Veldhuijzen, Irene K., van de Laar, Thijs J.W., Op de Coul, Eline L.M., van der Meer, Adriaan J.
Publicado 2022

Efficient SARS-CoV-2 Surveillance during the Pandemic-Endemic Transition Using PCR-Based Genotyping Assays

por Koets, Lianne, van Leeuwen, Karin, Derlagen, Maaike, van Wijk, Jalenka, Keijzer, Nadia, Feenstra, Jelena D. M., Gandhi, Manoj, Sorel, Oceane, van de Laar, Thijs J. W., Koppelman, Marco H. G. M.
Publicado 2023

Cost-Effectiveness of a JAK1/JAK2 Inhibitor vs a Biologic Disease-Modifying Antirheumatic Drug (bDMARD) in a Treat-to-Target Strategy for Rheumatoid Arthritis

por Van De Laar, Celine J, Oude Voshaar, Martijn A H, Fakhouri, Walid K H, Zaremba-Pechmann, Liliana, De Leonardis, Francesco, De La Torre, Inmaculada, Van De Laar, Mart A F J
Publicado 2020

Control Measures Used during Lymphogranuloma Venereum Outbreak, Europe

por Timen, Aura, Hulscher, Marlies E.J.L., Vos, Dieuwke, van de Laar, Marita J.W., Fenton, Kevin A., van Steenbergen, Jim E., van der Meer, Jos W.M., Grol, Richard P.T.M.
Publicado 2008

Monitoring Recently Acquired HIV Infections in Amsterdam, The Netherlands: The Attribution of Test Locations

por Slurink, Isabel A. L., van de Baan, Frank, van Sighem, Ard I., van Dam, Alje P., van de Laar, Thijs J. W., de Bree, Godelieve J., van Benthem, Birgit H. B., Op de Coul, Eline L. M.
Publicado 2021

Risk Factors for Sexual Transmission of Hepatitis C Virus Among Human Immunodeficiency Virus-Infected Men Who Have Sex With Men: A Case-Control Study

por Vanhommerig, Joost W., Lambers, Femke A. E., Schinkel, Janke, Geskus, Ronald B., Arends, Joop E., van de Laar, Thijs J. W., Lauw, Fanny N., Brinkman, Kees, Gras, Luuk, Rijnders, Bart J. A., van der Meer, Jan T. M., Prins, Maria
Publicado 2015

Direct-Acting Antiviral Treatment for Hepatitis C Genotypes Uncommon in High-Income Countries: A Dutch Nationwide Cohort Study

por Isfordink, Cas J, van de Laar, Thijs J W, Rebers, Sjoerd P H, Wessels, Els, Molenkamp, Richard, Knoester, Marjolein, Baak, Bert C, van Nieuwkoop, Cees, van Hoek, Bart, Brakenhoff, Sylvia M, Blokzijl, Hans, Arends, Joop E, van der Valk, Marc, Schinkel, Janke
Publicado 2021

Erratum to: Direct-Acting Antiviral Treatment for Hepatitis C Genotypes Uncommon in High-Income Countries: A Dutch Nationwide Cohort Study

por Isfordink, Cas J, van de Laar, Thijs J W, Rebers, Sjoerd P H, Wessels, Els, Molenkamp, Richard, Knoester, Marjolein, Baak, Bert C, van Nieuwkoop, Cees, van Hoek, Bart, Brakenhoff, Sylvia M, Blokzijl, Hans, Arends, Joop E, van der Valk, Marc, Schinkel, Janke
Publicado 2021